Return On Equity of Phathom Pharmaceuticals, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Phathom Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Phathom Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 77%, a 63% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2024 was 162%, a 67% decline from 2023.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2023 was 494%, a 56% decline from 2022.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2022 was 1127%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 77% -134% -63% 01 Jul 2025 30 Sep 2025
Q2 2025 111% -140% -56% 01 Apr 2025 30 Jun 2025
Q1 2025 137% -309% -69% 01 Jan 2025 31 Mar 2025
Q4 2024 162% -332% -67% 01 Oct 2024 31 Dec 2024
Q3 2024 211% -217% -51% 01 Jul 2024 30 Sep 2024
Q2 2024 251% -174% -41% 01 Apr 2024 30 Jun 2024
Q1 2024 446% +53% +13% 01 Jan 2024 31 Mar 2024
Q4 2023 494% -632% -56% 01 Oct 2023 31 Dec 2023
Q3 2023 429% +1359% 01 Jul 2023 30 Sep 2023
Q2 2023 426% +743% 01 Apr 2023 30 Jun 2023
Q1 2023 393% +566% 01 Jan 2023 31 Mar 2023
Q4 2022 1127% +1249% 01 Oct 2022 31 Dec 2022
Q3 2022 -930% -821% -754% 01 Jul 2022 30 Sep 2022
Q2 2022 -318% -219% -223% 01 Apr 2022 30 Jun 2022
Q1 2022 -173% -91% -112% 01 Jan 2022 31 Mar 2022
Q4 2021 -122% -53% -77% 01 Oct 2021 31 Dec 2021
Q3 2021 -109% -20% -23% 01 Jul 2021 30 Sep 2021
Q2 2021 -98% +77% +44% 01 Apr 2021 30 Jun 2021
Q1 2021 -82% +467% +85% 01 Jan 2021 31 Mar 2021
Q4 2020 -69% -8999% -101% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -351% -134% 01 Jul 2020 30 Sep 2020
Q2 2020 -176% -579% -143% 01 Apr 2020 30 Jun 2020
Q1 2020 -549% -727% -408% 01 Jan 2020 31 Mar 2020
Q4 2019 8930% +8749% +4843% 01 Oct 2019 31 Dec 2019
Q3 2019 262% 01 Jul 2019 30 Sep 2019
Q2 2019 403% 01 Apr 2019 30 Jun 2019
Q1 2019 178% 01 Jan 2019 31 Mar 2019
Q4 2018 181% 01 Oct 2018 31 Dec 2018

Phathom Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 162% -332% -67% 01 Jan 2024 31 Dec 2024
2023 494% -632% -56% 01 Jan 2023 31 Dec 2023
2022 1127% +1249% 01 Jan 2022 31 Dec 2022
2021 -122% -53% -77% 01 Jan 2021 31 Dec 2021
2020 -69% -8999% -101% 01 Jan 2020 31 Dec 2020
2019 8930% +8749% +4843% 01 Jan 2019 31 Dec 2019
2018 181% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.